Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs CVE✓SelectedUSD · CVEMRNA vs CVE performance historyLatest closeAs of-3.63%11/16
Stock and ETF performance explorer

MRNA vs CVE

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-8.1%
CVE return
+150.9%
Excess return
-159.0%
Maximum drawdown
-93.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioCVEExcessAlpha
1D-3.6%-2.9%-0.7%-3.4%
7D-20.0%+2.3%-22.3%-20.1%
30D-1.3%-14.3%+13.0%-0.1%
3M+240.0%-8.5%+248.5%+241.0%
6M+339.0%-7.5%+346.4%+339.6%
YTD+630.0%+69.6%+560.3%+568.0%
1Y+769.1%+58.3%+710.8%+701.8%
3Y+181.2%+74.6%+106.6%+152.1%
5Y-8.1%+155.6%-163.7%+11.6%
All-8.1%+150.9%-159.0%+11.6%

Cumulative growth

Daily Returns

Daily percentage return beside CVE.

Daily Out/Under-Performance

Portfolio return minus CVE return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CVE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded CVE wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling